Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. - Wikidata - awgldk - TriplyDB

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

http://www.wikidata.org/entity/Q31148247

about

Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment Current Awareness on Comparative and Functional Genomics A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients Clinical and multiple gene expression variables in survival analysis of breast cancer: Analysis with the hypertabastic survival model Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Regulation of mitosis and taxane response by Daxx and Rassf1.STAT3 can be activated through paracrine signaling in breast epithelial cells.Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-Set-Based F-Information and Water Swirl Algorithm of Human Gene Expression Data.Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.Biological convergence of cancer signatures Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.Future of personalized medicine in oncology: a systems biology approach.Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assay Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers.The impact of expression profiling on prognostic and predictive testing in breast cancer.Docetaxel in the treatment of breast cancer: current experience and future prospects.Epithelial-mesenchymal transition, cancer stem cells and treatment resistance.High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies.Predicted mechanisms of resistance to mTOR inhibitors.Breast cancer expression profiling: the impact of microarray testing on clinical decision making.Capecitabine-docetaxel combination treatment.Predicting risk of breast cancer recurrence using gene-expression profiling.Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.Pharmacogenetics and oncology treatment for breast cancer.Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients Development and validation of gene expression profile signatures in early-stage breast cancer.Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.Genomic predictors of outcome and treatment response in breast cancer.A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.

P2860

Q26824316-DAF897AE-A504-4004-AEFB-02493533B57E Q26824386-70C50622-58FE-4AC9-AEA2-81C8700AB27E Q26865458-75D6BDDF-2746-4FEF-B9C5-DDE7E0BC6D3C Q27486415-F4185519-E72F-448F-9A8D-24D93ED1CBD5 Q28477202-5087DEFA-392F-4C93-8FEA-9D1ABC0A3D2A Q29248640-925A4EA8-960B-4695-BB12-312D457A499C Q29617584-50029AAE-51F4-4975-9C57-50D665BB4BB0 Q29620020-B9456292-BCB7-4726-BBA3-476DCD3B4A5C Q30574064-471A4908-7343-4730-AB18-68EDC4750E0D Q30849602-0E07CBA9-7233-47EA-A9AB-40984D3D3748 Q31147890-EFFA4231-A1B2-4CFD-99FF-F363ED74F922 Q32182056-404F3BBC-E1F3-4359-8856-BA0828E97CE1 Q33410835-39CABE1E-8370-469E-AB3D-A8A39D5BA060 Q33640816-5888081B-C17A-435C-8609-2978C4FAD6D7 Q33761201-C037EDCC-74D7-469C-9F75-81CC651CF5A3 Q33896397-5EB7BE52-3266-422A-B63E-9B98CC24D1DC Q33898189-8ED70196-76BF-4CD2-A377-65A33218A847 Q34694605-C7E98CBF-02C7-4E6C-AEBF-E32A57C54174 Q34795754-780FA5C5-2200-4D39-AEA9-3BFA81378F4D Q35153559-771DC0FB-6BA9-49C8-9602-FDF8A1B6BA6C Q35258324-EEDAEBFE-8CA1-433A-B60E-2C509FDF91F1 Q35497722-DADF1DDB-7E30-49D0-843D-AE24790D0D55 Q35769768-82DD97DA-5045-4BB4-A0D8-5CD669C80A7D Q36235546-182FDD4A-6DD6-4F10-9B2B-17269D77FA55 Q36393056-4FD9C6AE-46F1-4B34-8B38-DA770F8AD225 Q36484592-F580AD47-A680-4B48-A186-574B27C19F7B Q36585744-95A46DFE-1FE2-4FF3-BD68-9E80C3C6589A Q36613933-3A5EC8CC-3989-468B-9E60-2151158483E8 Q36613965-7E24FE9B-EA9E-441B-B595-6089C44269A9 Q36691795-D9F586D2-1DEC-450B-AA36-AF33B975A5B2 Q36693275-652DA33A-87D0-459D-8217-998193400620 Q36698501-4C5AE4C2-E9AA-411A-9C21-6753E278BDA5 Q36719659-C2BAA221-D8A5-4660-91FE-D11F2D2E8934 Q36816034-CCA08D86-55AE-4D66-9810-933BAA833D5B Q36847243-43887D0A-4654-4D38-8CEB-7F51F962B6E5 Q37143757-EA6096DB-D032-4901-89B0-BFFBC79DF925 Q37384844-04A97397-A503-4D96-B8A1-EB4FECD7FE95 Q37389790-C28F9FCB-E3BE-40BD-B34C-4ECB17DBFFA2 Q37523889-9A99D9EC-95A9-4237-97DF-97A9BE82EBD3 Q37662215-23AEC144-5600-4BE8-9B71-AE7E856C8385

P2860

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

http://www.wikidata.org/entity/Q31148247

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Patterns of resistance and inc ...... ing in breast cancer patients.

@ast

Patterns of resistance and inc ...... ing in breast cancer patients.

@en

type

label

Patterns of resistance and inc ...... ing in breast cancer patients.

@ast

Patterns of resistance and inc ...... ing in breast cancer patients.

@en

prefLabel

Patterns of resistance and inc ...... ing in breast cancer patients.

@ast

Patterns of resistance and inc ...... ing in breast cancer patients.

@en

P1433

Q31148247-C8D07AE9-A807-4BBD-8698-AE4AAD8828D4

P1476

Q31148247-24D8B9E9-035E-4E23-87F3-6FD01D66A622

P2093

Q31148247-01627C2C-452B-4E82-92D4-4EA1C7EEECDD

Q31148247-0B2742EC-41C6-49F1-BC18-998213C60E4F

Q31148247-138396C7-0313-46A5-9273-8F1AB93AE641

Q31148247-5D1F61C3-7A69-4BEE-8013-852747BBD1BA

Q31148247-6FF5D8DB-FEC1-4800-8534-6AF941C013E5

Q31148247-72C39FC7-13F2-4351-8C06-3B64B81E2C64

Q31148247-9B67AECC-6E13-41EC-BFE5-2D933BAE4D2D

Q31148247-A5AD5156-CEA6-4DCC-94BA-1762DC7B2530

Q31148247-ADB62139-C2A6-4298-9994-E964889F0E64

Q31148247-C742BE73-9887-4607-815A-F17E78271691

P304

Q31148247-0C5EAC84-9D4C-4B02-B254-2952EBBDA5B6

P31

Q31148247-6261B359-3C10-4758-8FE3-C25F44C88926

P356

Q31148247-2490BFEF-86AF-4F97-9B53-BE4D841B77E9

P407

Q31148247-C74B1909-35C0-44E5-9CCD-2FC1F675BB23

P433

Q31148247-C42B4CB9-D6F7-46AB-9508-3FCBDFE593DC

P478

Q31148247-1F57F61B-B0CD-4FFC-8DE5-4F34C22AA415

P50

Q31148247-6CAA3AF9-C642-4482-B757-A8260FD501D5

P577

Q31148247-C4C7AF24-23E6-4C68-BDCE-310AEA6BBB87

P698

Q31148247-C0A93CF0-C46B-481E-A118-3867A3F78A1D

P356

JCO.2005.03.156

P1433

Journal of Clinical Oncology

P1476

Patterns of resistance and inc ...... ing in breast cancer patients.

@en

P2093

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

D Craig Allred

http://www.w3.org/2001/XMLSchema#string

Eric C Wooten

http://www.w3.org/2001/XMLSchema#string

Gary C Chamness

http://www.w3.org/2001/XMLSchema#string

Helen Wong

http://www.w3.org/2001/XMLSchema#string

Jenny C Chang

http://www.w3.org/2001/XMLSchema#string

M Carolina Gutierrez

http://www.w3.org/2001/XMLSchema#string

Mamta Kalidas

http://www.w3.org/2001/XMLSchema#string

Michael T Lewis

http://www.w3.org/2001/XMLSchema#string

Peter O'Connell

http://www.w3.org/2001/XMLSchema#string

P304

1169-1177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.03.156

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15718313

http://www.w3.org/2001/XMLSchema#string